Independent of the type of cell product, autologous or allogeneic, native or gene modified or the respective medical indication, the manufacturing of innovative cell-based therapeutics is highly complex. BioNTech IMFS is an industry leader in the development and manufacturing services for cell-based therapeutics. Our commitment is to provide the highest quality service to support the rapid clinical development and commercial manufacturing of our customers’ products.
With a proven track record, BioNTech IMFS covers the full range of manufacturing services for cellular therapies. Starting from tech transfer and process development over clinical trial support to market supply, always embedded in a comprehensive quality management system.
Dr. Andrea Schilz
Tel +49 (0) 6781 98550